CD4 and rheumatoid arthritis: The anti-RA mechanism of ginsenoside Rg3 is related to its efficacy in regulating the oxidative phosphorylation pathway, and enhancing the ability of CD4+ CD25+ Foxp3+ Treg cells to maintain peripheral immune tolerance, thereby resisting inflammation and immunosuppression (132).